Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Magnesium bioavailability after administration of sucrosomial® magnesium: results of an ex-vivo study and a comparative, double-blinded, cross-over study in healthy subjects.

Brilli E, Khadge S, Fabiano A, Zambito Y, Williams T, Tarantino G.

Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1843-1851. doi: 10.26355/eurrev_201803_14605.

PMID:
29630135
2.

Long-Chain Omega-3 Polyunsaturated Fatty Acids Modulate Mammary Gland Composition and Inflammation.

Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Talmadge JE.

J Mammary Gland Biol Neoplasia. 2018 Mar 25. doi: 10.1007/s10911-018-9391-5. [Epub ahead of print]

PMID:
29574638
3.

Lipid Inflammatory Mediators in Cancer Progression and Therapy.

Khadge S, Sharp JG, McGuire TR, Thiele GM, Talmadge JE.

Adv Exp Med Biol. 2017;1036:145-156. doi: 10.1007/978-3-319-67577-0_10.

PMID:
29275470
4.

Dietary omega-3 and omega-6 polyunsaturated fatty acids modulate hepatic pathology.

Khadge S, Sharp JG, Thiele GM, McGuire TR, Klassen LW, Duryee MJ, Britton HC, Dafferner AJ, Beck J, Black PN, DiRusso CC, Talmadge J.

J Nutr Biochem. 2018 Feb;52:92-102. doi: 10.1016/j.jnutbio.2017.09.017. Epub 2017 Oct 4.

PMID:
29175671
5.

Exploratory urinary metabolomics of type 1 leprosy reactions.

Mayboroda OA, van Hooij A, Derks R, van den Eeden SJ, Dijkman K, Khadge S, Thapa P, Kunwar CB, Hagge DA, Geluk A.

Int J Infect Dis. 2016 Apr;45:46-52. doi: 10.1016/j.ijid.2016.02.012. Epub 2016 Feb 26.

6.

Genetic Variation in Toll-Interacting Protein Is Associated With Leprosy Susceptibility and Cutaneous Expression of Interleukin 1 Receptor Antagonist.

Shah JA, Berrington WR, Vary JC Jr, Wells RD, Peterson GJ, Kunwar CB, Khadge S, Hagge DA, Hawn TR.

J Infect Dis. 2016 Apr 1;213(7):1189-97. doi: 10.1093/infdis/jiv570. Epub 2015 Nov 26.

7.

Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.

Khadge S, Banu S, Bobosha K, van der Ploeg-van Schip JJ, Goulart IM, Thapa P, Kunwar CB, van Meijgaarden KE, van den Eeden SJ, Wilson L, Kabir S, Dey H, Goulart LR, Lobato J, Carvalho W, Bekele Y, Franken KL, Aseffa A, Spencer JS, Oskam L, Otttenhoff TH, Hagge DA, Geluk A.

BMC Infect Dis. 2015 Oct 28;15:477. doi: 10.1186/s12879-015-1128-0.

8.

Gender moderates the effect of oxytocin on social judgments.

Hoge EA, Anderson E, Lawson EA, Bui E, Fischer LE, Khadge SD, Barrett LF, Simon NM.

Hum Psychopharmacol. 2014 May;29(3):299-304. doi: 10.1002/hup.2402.

PMID:
24911580
9.

Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Rivoire BL, Groathouse NA, TerLouw S, Neupane KD, Ranjit C, Sapkota BR, Khadge S, Kunwar CB, Macdonald M, Hawksworth R, Thapa MB, Hagge DA, Tibbals M, Smith C, Dube T, She D, Wolff M, Zhou E, Makhene M, Mason R, Sizemore C, Brennan PJ.

PLoS Negl Trop Dis. 2014 May 29;8(5):e2811. doi: 10.1371/journal.pntd.0002811. eCollection 2014. Erratum in: PLoS Negl Trop Dis. 2014 Jul;8(7):e3065. Kunwar, Chatra B [corrected to Kunwar, Chhatra B].

10.

T-cell regulation in lepromatous leprosy.

Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, van der Ploeg-van Schip JJ, Abebe M, Hussein J, Khadge S, Neupane KD, Hagge DA, Jordanova ES, Aseffa A, Ottenhoff TH, Geluk A.

PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2773. doi: 10.1371/journal.pntd.0002773. eCollection 2014 Apr.

11.

Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal.

Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D, Lockwood DN.

PLoS Negl Trop Dis. 2013;7(3):e2089. doi: 10.1371/journal.pntd.0002089. Epub 2013 Mar 7.

12.

Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal.

Bobosha K, Tang ST, van der Ploeg-van Schip JJ, Bekele Y, Martins MV, Lund O, Franken KL, Khadge S, Pontes MA, Gonçalves Hde S, Hussien J, Thapa P, Kunwar CB, Hagge DA, Aseffa A, Pessolani MC, Pereira GM, Ottenhoff TH, Geluk A.

Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:112-23.

13.

Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions.

Cogen AL, Walker SL, Roberts CH, Hagge DA, Neupane KD, Khadge S, Lockwood DN.

PLoS Negl Trop Dis. 2012;6(11):e1869. doi: 10.1371/journal.pntd.0001869. Epub 2012 Nov 1.

14.

The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions.

Walker SL, Roberts CH, Atkinson SE, Khadge S, Macdonald M, Neupane KD, Ranjit C, Sapkota BR, Dhakal S, Hawksworth RA, Mahat K, Ruchal S, Hamal S, Hagge DA, Lockwood DN.

Br J Dermatol. 2012 Jul;167(1):29-35. doi: 10.1111/j.1365-2133.2012.10891.x. Epub 2012 Jun 1.

PMID:
22348338
15.

Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.

Li W, Matsuoka M, Kai M, Thapa P, Khadge S, Hagge DA, Brennan PJ, Vissa V.

J Clin Microbiol. 2012 Mar;50(3):742-53. doi: 10.1128/JCM.05183-11. Epub 2011 Dec 14.

16.

Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.

Berrington WR, Macdonald M, Khadge S, Sapkota BR, Janer M, Hagge DA, Kaplan G, Hawn TR.

J Infect Dis. 2010 May 1;201(9):1422-35. doi: 10.1086/651559.

17.

The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans.

Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, Bang ND, Hagge DA, Khadge S, King MC, Hawn TR, Moens CB, Ramakrishnan L.

Cell. 2010 Mar 5;140(5):717-30. doi: 10.1016/j.cell.2010.02.013.

Supplemental Content

Loading ...
Support Center